Dipyridamole (Cadila Healthcare Limited)
Welcome to the PulseAid listing for the Dipyridamole drug offered from Cadila Healthcare Limited. This Decreased Platelet Aggregation [PE],Platelet Aggregation Inhibitor [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Cadila Healthcare Limited |
| NON-PROPRIETARY NAME: | Dipyridamole |
| SUBSTANCE NAME: | DIPYRIDAMOLE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Decreased Platelet Aggregation [PE],Platelet Aggregation Inhibitor [EPC] |
| ROUTE: | ORAL |
| DOSAGE FORM: | TABLET, FILM COATED |
| MARKETING CATEGORY NAME: | ANDA |
| START MARKETING DATE: | 2008-05-22 |
| END MARKETING DATE: | 0000-00-00 |
Dipyridamole HUMAN PRESCRIPTION DRUG Details:
| Item Description | Dipyridamole from Cadila Healthcare Limited |
| LABELER NAME: | Cadila Healthcare Limited |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 25(mg/1) |
| START MARKETING DATE: | 2008-05-22 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 65841-662_fcf151dd-e0b3-4a0c-b148-8e5be1342f2d |
| PRODUCT NDC: | 65841-662 |
| APPLICATION NUMBER: | ANDA040874 |
Other DIPYRIDAMOLE Pharmaceutical Manufacturers / Labelers:
